FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen

Why It Matters

By widening the pool of FDA‑cleared filters, the decision could boost sunscreen adoption and address the trust gap that has limited protection against the nation’s most common cancer. It also signals a shift toward more competitive, consumer‑friendly products in the U.S. market.

Key Takeaways

• FDA adds bemotrizinol to GRASE list alongside zinc oxide, titanium dioxide
• Ingredient offers broad-spectrum UVA/UVB protection with less white cast
• Approval may spur US sunscreens to match Asian market standards
• Industry sees chance to replace controversial filters like avobenzone
• Trust gap remains; FDA urged to act faster on unsafe chemicals

Pulse Analysis

Skin cancer remains the most common malignancy in the United States, with roughly one in five people projected to develop it by age 70. Despite clear public‑health benefits, American sunscreen usage has lagged due to lingering doubts about ingredient safety and a perception that products feel greasy or leave a white cast. The regulatory framework treats sunscreen filters as over‑the‑counter drugs, imposing rigorous testing that has slowed the introduction of new, potentially safer chemicals compared with the EU and Asian markets.

Bemotrizinol, known internationally as BEMT, finally cleared the FDA’s “generally recognized as safe and effective” (GRASE) hurdle after extensive irritation, sensitization, two‑year carcinogenicity, and reproductive studies. Its molecular structure absorbs both UVA and UVB rays efficiently, offering protection comparable to the best European formulas while reducing the chalky appearance typical of mineral sunscreens. For formulators, BEMT’s high photostability means it can replace less stable filters such as avobenzone, allowing lighter textures and higher SPF ratings without compromising safety.

The approval opens a commercial window for brands eager to launch hybrid sunscreens that blend BEMT with zinc oxide or titanium dioxide, mirroring the sleek, transparent products popular in South Korea and Japan. Analysts anticipate a wave of new launches by major players like Procter & Gamble and DSM‑Firmenich before year‑end, potentially revitalizing consumer trust and driving higher usage rates. However, experts caution that the broader trust issue will persist until the FDA accelerates the removal of filters lacking robust safety data, reinforcing sunscreen as one layer of a comprehensive sun‑protection strategy.